rs587783399
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PP4PM2_SupportingPM6_Strong
This summary comes from the ClinGen Evidence Repository: The c.146-1G>A variant in CDKL5 (NM_001323289.2) is absent from gnomAD v2 (PM2_supporting). The c.146-1G>A variant in CDKL5 is predicted to affect a canonical splice site and lead to a truncated or absent protein in a CDKL5 where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the gene is pathogenic (PVS1). The c.146-1G>A variant has been reported in an individual with a clinical phenotype suggestive of CDKL5 disorder (internal database - International CDKL5 Disorder Database) (PP4). The c.146-1G>A variant in CDKL5 has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with CDKL5 disorder (internal database - International CDKL5 Disorder Database) (PM6_strong). In summary, the c.146-1G>A variant in CDKL5 is classified as pathogenic for CDKL5 disorder based on the ACMG/AMP criteria (PM2_supporting, PVS1, PP4, PM6_strong). LINK:https://erepo.genome.network/evrepo/ui/classification/CA171613/MONDO:0100039/034
Frequency
Consequence
NM_001323289.2 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.146-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 17 | ENST00000623535.2 | NP_001310218.1 | ||
CDKL5 | NM_001037343.2 | c.146-1G>A | splice_acceptor_variant, intron_variant | Intron 5 of 21 | NP_001032420.1 | |||
CDKL5 | NM_003159.3 | c.146-1G>A | splice_acceptor_variant, intron_variant | Intron 4 of 20 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
CDKL5 disorder Pathogenic:2
The c.146-1G>A variant in CDKL5 (NM_001323289.2) is absent from gnomAD v2 (PM2_supporting). The c.146-1G>A variant in CDKL5 is predicted to affect a canonical splice site and lead to a truncated or absent protein in a CDKL5 where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the gene is pathogenic (PVS1). The c.146-1G>A variant has been reported in an individual with a clinical phenotype suggestive of CDKL5 disorder (internal database - International CDKL5 Disorder Database) (PP4). The c.146-1G>A variant in CDKL5 has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with CDKL5 disorder (internal database - International CDKL5 Disorder Database) (PM6_strong). In summary, the c.146-1G>A variant in CDKL5 is classified as pathogenic for CDKL5 disorder based on the ACMG/AMP criteria (PM2_supporting, PVS1, PP4, PM6_strong). -
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant is absent from gnomAD (PM2_Supporting). Has been observed in 1 individual with phenotypes consistent with CDKL5 disorder (PMID: 25657822). -
Developmental and epileptic encephalopathy, 2 Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at